Drug profile · INN
diclofenac sodium
DICLOFENAC SODIUM
diclofenac sodium (DICLOFENAC SODIUM) is a cyclooxygenase inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: ophthalmic. Current US regulatory status: approved.
Drug details — diclofenac sodium
- US status
- approved
- Class
- —
- Route
- OPHTHALMIC
- Patents
- 0
- Programs
- 8
- Data quality
- 0.89
Quick answer
diclofenac sodium (DICLOFENAC SODIUM) is a cyclooxygenase inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: ophthalmic. Current US regulatory status: approved.
Key facts
Mechanism of action
Cyclooxygenase inhibitor
Primary target: Cyclooxygenase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is diclofenac sodium?
diclofenac sodium (DICLOFENAC SODIUM) is a cyclooxygenase inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: ophthalmic. Current US regulatory status: approved.
What is the brand name for diclofenac sodium?
DICLOFENAC SODIUM is a marketed brand name for diclofenac sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of diclofenac sodium?
diclofenac sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.